Results 31 to 40 of about 4,498,317 (372)

Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective “Real Life” analysis of activity and safety [PDF]

open access: yes, 2015
Abiraterone acetate (AA) is a potent, selective androge (CYP17) biosynthesis inhibitor, which showed to improve overall survival (HR = 0.646) in mCRPC patients progressing after docetaxel.
A., Giuli   +16 more
core   +1 more source

The importance of greater speed in drug development for advanced malignancies

open access: yesCancer Medicine, 2018
It takes on average 6–12 years to develop new anticancer drugs from discovery to approval. Effective new agents prolong survival. To demonstrate the importance of rapid drug approval, we calculated life‐years potentially saved if selected agents were ...
David J. Stewart   +9 more
doaj   +1 more source

How Compounding Pharmacies Fill Critical Gaps in Pediatric Drug Development Processes: Suggested Regulatory Changes to Meet Future Challenges

open access: yesChildren, 2022
Drugs administered to children in the United States fall into two broad categories: (1) those that have followed the US Food and Drug Administration (US-FDA) pediatric drug approval process and are marketed as finished dosage forms with pediatric ...
Robert B. MacArthur   +3 more
doaj   +1 more source

New Drugs Approved in 2009 [PDF]

open access: yesBaylor University Medical Center Proceedings, 2010
The article briefly reviews selected new drug entities approved by the Food and Drug Administration in 2009.
Sarah Brooks, Erin Sears
openaire   +3 more sources

Analysis of Control Arm Quality in Randomized Clinical Trials Leading to Anticancer Drug Approval by the US Food and Drug Administration.

open access: yesJAMA Oncology, 2019
Importance To date, an empirical evaluation of the quality of control arms in randomized clinical trials (RCTs) leading to anticancer drug approvals by the US Food and Drug Administration (FDA) has not been undertaken.
T. Hilal, M. Sonbol, V. Prasad
semanticscholar   +1 more source

Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union

open access: yesFrontiers in Pharmacology, 2021
Several advanced therapy medicinal products (ATMPs) have been approved in the European Union (EU). The aim of this study is to analyse the methodological features of the clinical trials (CT) that supported the marketing authorization (MA) of the approved
Carolina Iglesias-Lopez   +5 more
doaj   +1 more source

Hyperbolic Molecular Representation Learning for Drug Repositioning [PDF]

open access: yesarXiv, 2022
Learning accurate drug representations is essential for task such as computational drug repositioning. A drug hierarchy is a valuable source that encodes knowledge of relations among drugs in a tree-like structure where drugs that act on the same organs, treat the same disease, or bind to the same biological target are grouped together.
arxiv  

FDA-APPROVED INDICATIONS OF ADRENOCORTICOTROPIC HORMONE (ACTH) AS A DRUG: DOES IT HAVE A PLACE IN DISEASE MANAGEMENT TODAY?

open access: yesCentral Asian Journal of Medical Hypotheses and Ethics, 2023
ACTH is a pituitary hormone important for proper function of adrenal glands, cortisol production as well as human physiology in general.  It is involved in the pathogenesis of several endocrine disorders like Cushing syndrome and can be a useful ...
George Iliopoulos, Dimitrios Daoussis
doaj   +1 more source

Deep Graph Convolutional Network and LSTM based approach for predicting drug-target binding affinity [PDF]

open access: yesarXiv, 2022
Development of new drugs is an expensive and time-consuming process. Due to the world-wide SARS-CoV-2 outbreak, it is essential that new drugs for SARS-CoV-2 are developed as soon as possible. Drug repurposing techniques can reduce the time span needed to develop new drugs by probing the list of existing FDA-approved drugs and their properties to reuse
arxiv  

United States FDA drug approvals are persistent and polycyclic: Insights into economic cycles, innovation dynamics, and national policy [PDF]

open access: yes, 2020
It is challenging to elucidate the effects of changes in external influences (such as economic or policy) on the rate of US drug approvals. Here, a novel approach, termed the Chronological Hurst Exponent (CHE), is proposed, which hypothesizes that changes in the long-range memory latent within the dynamics of time series data may be temporally ...
arxiv   +1 more source

Home - About - Disclaimer - Privacy